COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,016 | -27.8% | 37,972 | -17.6% | 0.00% | 0.0% |
| Q2 2023 | $196,805 | -24.6% | 46,090 | +20.8% | 0.00% | 0.0% |
| Q1 2023 | $261,049 | +71814.3% | 38,165 | -16.8% | 0.00% | -50.0% |
| Q4 2022 | $363 | -16.2% | 45,851 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $433 | -99.9% | 45,060 | +6.3% | 0.00% | +100.0% |
| Q2 2022 | $307,000 | -44.4% | 42,398 | -0.8% | 0.00% | -50.0% |
| Q1 2022 | $552,000 | -6.1% | 42,759 | +15.9% | 0.00% | 0.0% |
| Q4 2021 | $588,000 | -1.0% | 36,890 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $594,000 | +9.8% | 36,890 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $541,000 | -3.2% | 39,089 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $559,000 | -15.6% | 38,239 | +0.4% | 0.00% | -33.3% |
| Q4 2020 | $662,000 | 0.0% | 38,081 | +5.4% | 0.00% | 0.0% |
| Q3 2020 | $662,000 | +3.3% | 36,126 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $641,000 | – | 35,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |